BioCentury | Jul 9, 2020
Finance
July 8 Quick Takes: CapitalBio raises $113M, plans Shanghai IPO; plus Aidea, CF PharmTech, Denovo, Nucleai and Vaxdyn
...a series A round led by Debiopharm's venture capital fund. Existing investors Vertex Ventures and Grove Ventures...
